rsna 2013 mammography systems women's healthcare ge sensory suite

January 6, 2014 — GE Healthcare showcased its SensorySuite “cocoon” experience at the Radiological Society of North America Annual Meeting (RSNA 2013). This 3-D, fully immersive video simulates SensorySuite by plunging participants into the overall SensorySuite patient experience. SensorySuite surrounds a woman with an interactive mammography experience designed to simultaneously stimulate three senses — sight, smell and hearing — helping to distract the patient from the discomfort, pain and anxiety of a mammogram.
 
“Sensory Suite exemplifies our vision by capturing the essence of a woman’s sense of serenity through a calming, surreal environment while facilitating the completion of her exam with the most state-of-the-art mammography unit,” said Kathy Schilling, M.D., medical director, and Shakira Sarquis-Kolber, director, Women’s Imaging Boca Raton, Fla. “It is the perfect combination of high-tech and high-touch.”
 
“During the mammogram, our patients are generally stressed and tense,” said Dr. André Crèvecoeur, CEO, Center of Senology, Liége, Belgium. “They fear in one hand that it will hurt and in the other hand the result. We acquired SensorySuite seven months ago, and we had very positive feedback from our patients.”
 
The November 2013 SensorySuite Marketing Research Study, performed with 250 patients in two different SensorySuite sites, showed that 64.4 percent of women felt relaxed during the mammogram examination, and 99.6 percent of all the patients were likely to return to the same facility for their next mammogram.
 
By giving women the control to choose from one of three environmental ambiances — seaside, garden or waterfall, SensorySuite aims to encourage better overall mammography, cooperation and compliance. SensorySuite is available for use with existing or new Senographe Essential, Senographe Care or Senographe DS systems.
 
For more information: www.gehealthcare.com, www.rsna.org

Related Content

News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
Subscribe Now